Starting Jan. 1, 2025, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into ...
Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.
On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...
Investor's Business Daily on MSN21h
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly ReviewThe stock market rebounded to or above key levels on tame inflation data and strong bank earnings. Many stocks flashed buy ...
JPMorgan posts record profits, Lululemon raises guidance, Cogeco kickstarts three-year plan, and UnitedHealth beats ...
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt ...
Company shares soared Friday after leaders told analysts they have made progress improving one of the biggest concerns facing the industry, shrinking prescription reimbursement, and said their ...
Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company. The U.S ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback